Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...
In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in ...
Fungal infections are becoming deadlier as drug resistance spreads and treatment options stall. Researchers at McMaster University discovered that a molecule called butyrolactol A can dramatically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback